• Products
  • Manufacturing Services
  • Quality
  • Knowledge Center
  • About Us
Home image

Powering the Future of Medicine®

As a critical raw materials supplier and manufacturer, we've constantly pushed the raw materials space into the future to ensure our clients have the highest-quality building blocks to develop and commercialize future therapies.

Learn More

Services

  • Protein Development

    Akron offers comprehensive recombinant protein and nuclease development and manufacturing under cGMP compliance. Our approach to developing novel cytokines and gene editing tools is to establish a strong foundation through extensive investigation and optimization, enabling a seamless transition to large-scale production.

    Learn More

  • Custom Media & Buffer Services

    Capitalizing on our established platform for manufacturing cGMP-compliant, clinical-grade ancillary products, Akron is well-positioned to provide custom development and manufacturing to accelerate the commercialization of advanced therapies.

    Learn More

  • Transfection & Transduction Reagents

    We offer cGMP-compliant viral transduction enhancers and non-viral transfection reagents and solutions to enable your therapeutic programs’ success. We offer flexible filling capabilities and several manufacturing environments to meet your needs.

    Learn More

Products

  • Cytokines & Growth Factors

    Akron’s high-quality cGMP Recombinant Proteins offer the consistency, safety, and efficacy that empower today’s leading clinical and commercial cell therapy companies.

    Learn More

  • Human Plasma Derived Products

    Akron’s proven blood products deliver safety and performance backed by robust and redundant supply. Because you can’t afford to compromise.

    Learn More

  • Media & Media Supplements

    We offer critical media and media supplements in both cGMP and high-quality research grade.

    Learn More

  • Closed System Solutions (CSS)™

    Our CSS product line is available in single-use, ready-to-use bags with weldable tubing to ensure consistency and sterility. This product line was developed to integrate optimally dosed, cGMP-compliant blood-derived products and liquid cytokines across manufacturing platforms.

    Learn More

Upcoming Events
Feb
1
February 1 - 5, 2026
Advancing Manufacture of Cell and Gene Therapies ​IX
Hilton Head, SC, USA

Our Business Development Director, Lexah Lhu, is heading to Hilton Head, SC, to kick off our 2026 conference season! Connect with him to learn how our off-the-shelf ancillary materials and custom development services can support your Cell and Gene Therapies.

Visit Website
Upcoming Events
Sep
7
September 7 - 9, 2026
Advanced Therapies Europe
Barcelona, Spain

Our Director of Business Development, Sara Padrell, will be attending this year's Advanced Therapies Europe. Schedule a meeting with her to learn about our products and services. See you there!
Visit Website
Advanced Therapies Week - Phacilitate
San Diego, CA, USA See More
February 9 - 12,
2026
CAR-TCR Europe
London, UK See More
February 24 - 26,
2026
Advanced Therapies
ExCel, London, UK See More
March 17 - 18,
2026
Wisconsin Stem Cell Symposium
Fitchburg, WI, USA See More
April 15,
2026
BPD Cell and Gene Therapy Symposium & Vendor Show
Chapel Hill, NC See More
April 24,
2026
Cell & Gene Meeting on the Med
Rome, Italy See More
April 28 - 30,
2026
ISCT Annual Meeting
Dublin, Ireland See More
May 6 - 9
2026
ASGCT Annual Meeting
Boston, MA, USA See More
May 11 - 15,
2026
Cell and Gene Therapy Products (CGTP) Symposium
Rockville, MD, USA See More
June 9 - 11,
2026
ISSCR 2026 Annual Meeting
Montreal, Canada See More
July 8 - 11,
2026
See all upcoming events
Latest News Annoucement

Jan 22, 2025

Terumo Blood and Cell Technologies and Akron Bio Complete Collaborative Study on MSC Expansion Using Quantum Flex

Read More
Recent News

Jan 16, 2025

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform

Dec 21, 2023

Multiply Labs and Akron Bio Partner to Automate the Use of cGMP-Compliant Liquid Cytokines in Cell Therapy Manufacturing

Jan 17, 2023

Akron Bio Receives Eligibility Confirmation from PMDA in Japan for the Commercialization of Virus Inactivated Human Fibronectin in Clinical Cell Therapy Manufacturing
See more in Newsroom
About Akron Bio

We support the advancement of cell and gene therapies through our portfolio of cytokines and media supplements, along with a comprehensive suite of manufacturing services—including the production of proteins, media and buffers, and transfection and transduction reagents. We ensure your raw materials are as innovative as your therapies.

Learn more